EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Effects of an Anti-Sialyl Lewis x Antibody in a Murine Model of Acute Lung Injury

Wenxin Liu, Wei Xiong, Wei Liu, Zihong Wei, Hirohito Abo, Hiroto Kawashima

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy · 2023

DOI: 10.1089/mab.2023.0001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2023. Verfasst von Wenxin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Lipopolysaccharides, Acute Lung Injury. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute respiratory distress syndrome is a life-threatening acute lung injury (ALI) characterized by the destruction of alveoli leading to pulmonary edema. The infiltration and activation of inflammatory cells and production of inflammatory cytokines are both involved in the pathogenesis of ALI. Here, we show that the infiltration of neutrophils, major inflammatory cells causing ALI, into the lung is mediated by sialyl Lewis x (sLe x ) glycans, which can be efficiently suppressed by a monoclonal antibody (mAb) against these glycans. In fucosyltransferase-IV and -VII double-deficient mice lacking sLe x expression, neutrophil infiltration into the lung was significantly suppressed compared with that observed in wild-type mice in a lipopolysaccharide (LPS)-induced ALI model. Administration of a highly specific anti-sLe x mAb F2 3 hours after LPS administration significantly suppressed pulmonary neutrophil infiltration, accompanied by the reduced induction of inflammatory cytokines. It was consistently indicated from ex vivo cell rolling assay that mAb F2 blocked the rolling of mouse neutrophils on P-selectin-expressing cells. Overall, these results indicate that the sLe x glycan could serve as a therapeutic target against ALI, and also that mAb F2 would be useful for specific targeting of this glycan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesAcute Lung InjuryMiceAnimalsSialyl Lewis X AntigenDisease Models, AnimalAntibodies, MonoclonalOligosaccharidesLungPolysaccharidesCytokines

Stichwörter der Autor:innen

P-selectinacute lung injuryanti-glycan antibodyleukocyte infiltrationneutrophilsialyl Lewis x

Substanzen

Sialyl Lewis X AntigenLipopolysaccharidesAntibodies, MonoclonalOligosaccharidesPolysaccharidesCytokines

Autor:innen und Institutionen

  • Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Zitieren

APA

Liu, W., Xiong, W., Liu, W., Wei, Z., Abo, H., & Kawashima, H. (2023). Therapeutic Effects of an Anti-Sialyl Lewis x Antibody in a Murine Model of Acute Lung Injury. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. https://doi.org/10.1089/mab.2023.0001

Vancouver

Liu W, Xiong W, Liu W, Wei Z, Abo H, Kawashima H. Therapeutic Effects of an Anti-Sialyl Lewis x Antibody in a Murine Model of Acute Lung Injury. Monoclonal Antibodies in Immunodiagnosis & Immunotherapy. 2023. doi:10.1089/mab.2023.0001

BibTeX
@article{Liu2023,
  author = {Liu, Wenxin and Xiong, Wei and Liu, Wei and Wei, Zihong and Abo, Hirohito and Kawashima, Hiroto},
  title = {Therapeutic Effects of an Anti-Sialyl Lewis x Antibody in a Murine Model of Acute Lung Injury},
  journal = {Monoclonal Antibodies in Immunodiagnosis & Immunotherapy},
  year = {2023},
  doi = {10.1089/mab.2023.0001}
}
Kostenlos starten →